A London HPV self-sampling pilot

Not Applicable

Completed

• Conditions: Cervical cancer; Cancer; Malignant neoplasms of female genital organs

• Registration Number: ISRCTN23940319
• Lead Sponsor: Queen Mary University of London

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-25
• Study Completion: 2021-01-31
• Last Update Posted: 8 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 3196

Inclusion Criteria

1. Women aged 25-64 years
2. Eligible for cervical screening
3. At least 6 months overdue (i.e. no cervical screening recorded in the GP records in the past 3.5 years if aged 25-49 or 5.5 years if aged 50-64)

Exclusion Criteria

Women unable to provide informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
This is a pilot study therefore there is no formal primary outcome measure. The study will calculate measures of feasibility and acceptability such as the proportion of eligible women who are offered kits, accept and return a self-sample following each intervention (i.e. (i) opportunistic offer of self-sampling kits, (ii) women invited to order a self-sampling kit, and (iii) women sent self sampling kit) at 6 months and 12 months after the invitation/offer of self sampling

Secondary Outcome Measures

Name	Time	Method
1. The proportion of eligible women who test HPV positive and a) attend for follow up (cytology or colposcopy) within 6 months of testing HPV positive on a SS and b) who are treated for CIN2+<br>2. Coverage” of cervical screening following different interventions – when additionally counting an HPV negative test on self-sample as screened”<br>3. Use of website in the intervention arm (women invited to order a kit)